|Articles|January 29, 2021
Top questions answered on challenging HCP assays
Author(s)Cytiva
Cytiva experts answer your top questions about challenging host cell protein assays to improve risk mitigation.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
2
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
3
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
